Episurf Medical AB (publ) (FRA:16E)

Market Cap	8.26M +14.0%
Revenue (ttm)	1.94M +12.6%
Net Income	-5.68M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	394
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0253
Beta	n/a
RSI	48.12
Earnings Date	Feb 6, 2026

About Episurf Medical AB

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The c...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2008
• Employees: 26
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 16E

Financial Performance

In 2024, Episurf Medical AB's revenue was 20.60 million, an increase of 4.04% compared to the previous year's 19.80 million. Losses were -76.00 million, -19.83% less than in 2023.

Financial numbers in SEK